These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

49 related articles for article (PubMed ID: 7185717)

  • 1. [Pharmacokinetic studies on the penetration and distribution of bupranolol in the rabbit eye].
    Schmitz J; Dahnke HG; Zemitis A; Koglin K; Mosebach KO; Dardenne MU
    Fortschr Ophthalmol; 1982; 79(4):374-8. PubMed ID: 7185717
    [No Abstract]   [Full Text] [Related]  

  • 2. A radioautographic study on the incorporation of 14C-bupranolol (beta-blocking agent) into the rabbit eye.
    Tsukahara S; Yoshida K; Nagata T
    Histochemistry; 1980; 68(3):237-44. PubMed ID: 7462003
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Scanning electron microscopic studies on the cornea of rabbit after chronic topical administration of 1% bupranolol (author's transl)].
    Araki M; Ogata T
    Nippon Ganka Gakkai Zasshi; 1980 Sep; 84(9):1376-84. PubMed ID: 7223567
    [No Abstract]   [Full Text] [Related]  

  • 4. [Electron microscopic observations of the ciliary epithelium of rabbit after chronic topical administration of 1% bupranolol (author's transl)].
    Araki M; Ogata T
    Nippon Ganka Gakkai Zasshi; 1980 Oct; 84(10):1731-7. PubMed ID: 7257991
    [No Abstract]   [Full Text] [Related]  

  • 5. [Aspect on corneal permeability of bupranolol (author's transl)].
    Iwata S; Ohtani Y; Osada E; Ogino H
    Yakugaku Zasshi; 1980 Apr; 100(4):402-6. PubMed ID: 7431212
    [No Abstract]   [Full Text] [Related]  

  • 6. [Studies of bupranolol therapy for glaucoma. 1. Ocular penetration and hypotensive effect (author's transl)].
    Komuro S; Nanba H; Takase M
    Nippon Ganka Gakkai Zasshi; 1979 Jun; 83(6):537-41. PubMed ID: 484390
    [No Abstract]   [Full Text] [Related]  

  • 7. [Effect of topical bupranolol on glaucoma eyes (author's transl)].
    Miki H; Moriyama R; Itagaki Y
    Nippon Ganka Gakkai Zasshi; 1981 Feb; 85(2):169-74. PubMed ID: 7258011
    [No Abstract]   [Full Text] [Related]  

  • 8. Cardiovascular effects of transdermally delivered bupranolol in rabbits: effect of chemical penetration enhancers.
    Babu RJ; Dhanasekaran M; Vaithiyalingam SR; Singh PN; Pandit JK
    Life Sci; 2008 Jan; 82(5-6):273-8. PubMed ID: 18096189
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Determination of the beta-adrenoceptor blocking drug bupranolol in plasma and tissues of the rat by high-performance liquid chromatography with ultraviolet detection.
    Winkler H; Lemmer B
    J Chromatogr; 1984 Jul; 309(1):193-7. PubMed ID: 6480767
    [No Abstract]   [Full Text] [Related]  

  • 10. Ocular penetration of topical Delta9-tetrahydrocannabinol from rabbit corneal or cul-de-sac application site.
    Green KE; Kearse CE
    Curr Eye Res; 2000 Jul; 21(1):566-70. PubMed ID: 11035538
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficient intraocular penetration of topical anti-TNF-alpha single-chain antibody (ESBA105) to anterior and posterior segment without penetration enhancer.
    Ottiger M; Thiel MA; Feige U; Lichtlen P; Urech DM
    Invest Ophthalmol Vis Sci; 2009 Feb; 50(2):779-86. PubMed ID: 18757511
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Epinephrine distribution after topical administration to phakic and aphakic eyes.
    Kramer SG
    Trans Am Ophthalmol Soc; 1980; 78():947-82. PubMed ID: 7257075
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ocular aspirin distribution: a comparison of intravenous, topical, and coulomb-controlled iontophoresis administration.
    Voigt M; Kralinger M; Kieselbach G; Chapon P; Anagnoste S; Hayden B; Parel JM
    Invest Ophthalmol Vis Sci; 2002 Oct; 43(10):3299-306. PubMed ID: 12356838
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Topical and systemic absorption in delivery of dexamethasone to the anterior and posterior segments of the eye.
    Sigurdsson HH; Konráethsdóttir F; Loftsson T; Stefánsson E
    Acta Ophthalmol Scand; 2007 Sep; 85(6):598-602. PubMed ID: 17645424
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Bupranolol in the treatment of primary glaucoma].
    Oancea I; Călugăru M
    Rev Chir Oncol Radiol O R L Oftalmol Stomatol Ser Oftalmol; 1981; 25(3):219-22. PubMed ID: 6460297
    [No Abstract]   [Full Text] [Related]  

  • 16. Route of penetration of topically instilled nipradilol into the ipsilateral posterior retina.
    Mizuno K; Koide T; Shimada S; Mori J; Sawanobori K; Araie M
    Invest Ophthalmol Vis Sci; 2009 Jun; 50(6):2839-47. PubMed ID: 19218605
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Transscleral Coulomb-controlled iontophoresis of methylprednisolone into the rabbit eye: influence of duration of treatment, current intensity and drug concentration on ocular tissue and fluid levels.
    Behar-Cohen FF; El Aouni A; Gautier S; David G; Davis J; Chapon P; Parel JM
    Exp Eye Res; 2002 Jan; 74(1):51-9. PubMed ID: 11878818
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Topical nipradilol: effects on optic nerve head circulation in humans and periocular distribution in monkeys.
    Mizuno K; Koide T; Saito N; Fujii M; Nagahara M; Tomidokoro A; Tamaki Y; Araie M
    Invest Ophthalmol Vis Sci; 2002 Oct; 43(10):3243-50. PubMed ID: 12356831
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Mitomycin C concentrations in rabbit ocular tissues after topical administration during glaucoma filtration surgery].
    Xia X; Huang P; Jiang Y; Wu Z; Cheng B; Xia L
    Hunan Yi Ke Da Xue Xue Bao; 1997; 22(4):307-9. PubMed ID: 9868082
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacokinetics and posterior segment biodistribution of ESBA105, an anti-TNF-alpha single-chain antibody, upon topical administration to the rabbit eye.
    Furrer E; Berdugo M; Stella C; Behar-Cohen F; Gurny R; Feige U; Lichtlen P; Urech DM
    Invest Ophthalmol Vis Sci; 2009 Feb; 50(2):771-8. PubMed ID: 18757508
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.